Reported 1,137 shares, down 39 (3.3%) from the prior quarter.
Reported value -15.4%; share count -3.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-06-30 | 16600 |
| 2023-09-30 | 17629 |
| 2023-12-31 | 17745 |
| 2024-03-31 | 15021 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2024 | Reduced | 0 | -1,137 (-100.0%) | 0 | $0 | 2024-08-14 | |
| Q1 2024 | Reduced | 1,137 | -39 (-3.3%) | < 0.01% | $15,021 | 2024-05-15 | |
| Q4 2023 | Unchanged | 1,176 | 0 (0.0%) | < 0.01% | $17,745 | 2024-02-13 | |
| Q3 2023 | Reduced | 1,176 | -100 (-7.8%) | < 0.01% | $17,629 | 2023-11-15 | |
| Q2 2023 | New | 1,276 | +1,276 (0.0%) | < 0.01% | $16,600 | 2023-08-14 |
Who else reported the position
18 managers reported ACORDA THERAPEUTICS INC for Q1 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Davidson Kempner Capital Management LP | Unchanged | 55,145 | 0 | < 0.01% | $689,312 | 4 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Added | 46,761 | +1,000 | < 0.01% | $618,000 | 4 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Unchanged | 33,691 | 0 | < 0.01% | $420,000 | 4 qtrs |
| VANGUARD GROUP INC | Added | 19,260 | +8,452 | < 0.01% | $254,444 | 3 qtrs |
| BlackRock Inc | Reduced | 6,107 | -521 | < 0.01% | $80,680 | 4 qtrs |
| WELLS FARGO & COMPANY MN | Reduced | 3,736 | -5 | < 0.01% | $49,357 | 4 qtrs |
| MORGAN STANLEY This report | Reduced | 1,137 | -39 | < 0.01% | $15,021 | 4 qtrs |
| Russell Investments Group Ltd | Unchanged | 300 | 0 | < 0.01% | $3,750 | 4 qtrs |
| UBS Group AG | Reduced | 106 | -192 | < 0.01% | $1,400 | 3 qtrs |
| Tower Research Capital LLC TRC | New | 103 | +103 | < 0.01% | $1,361 | 4 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2024
- Filed
- May 15, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,127
- Shared
- 0
- None
- 10
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.